VTT Technical Research Centre of Finland has developed a mobile app and a thumb-size tool called Beat2Phone that can help save you stroke in the form of cerebral infarctions at an early stage, throughout asymptomatic irregular heart rhythm or atrial fibrillation. The mobile device, which detects arrhythmia (abnormal heartbeat) has been tested with splendid results for two years in real-life situations in cooperation with people from Turku University Central Hospital.
An irregular heartbeat has a tendency to remain undiagnosed, if no symptoms are detected at some stage in Holter monitoring of heart rate and rhythm. Timo Varpula, Principal Scientist at VTT remarked, With the mobile device developed by VTT, users can register their ECG signal whenever arrhythmia or other heart symptoms occur. The device is also suitable for pre- and post-surgery monitoring of heart patients at home. There is no need for patients to visit a hospital, because the data is sent automatically from a mobile phone to medical staff via a cloud service.
Arrhythmia Notifications Immediately In Your Cellphone
Handy and smooth to use, Beat2Phone appropriately measures the user’s heart rate and heart rate variability as a way to detect not only an abnormal heartbeat, but additionally overburdening and extended pressure. A high resting heart rate and low heart rate variability are indicators of pressure.
The Android app and device measure ECG alerts at a totally excessive sampling rate, becoming aware of individual heart beats and measure the interval between consecutive beats. The tool additionally includes activity and position sensors. It has a flexible strap that make Beat2Phone comfortable to put on.
The mobile device has been used by heart patients at Turku University Central Hospital, in addition to top athletes with heart conditions, who have been tremendously happy with it. Pinnacle athletes and professional sportspersons must monitor their heart activity often, because changes in ECG can be an indicator of myocarditis or different serious conditions.
The device has so far been tested by around 30 users, some of whom have also worn the device at night. The test users are people who’ve stated heart signs, but who have not had signs and symptoms at some stage in advanced Holter tracking.
In these tests, the device helped determine atrial fibrillation, arrhythmia and a cardiac conduction ailment. The sufferers were admitted for further checks when they had shown their Beat2Phone electrocardiograms to a health practitioner. People who have harmless abnormal heartbeats have additionally mentioned a good quality of life because of the measuring device alleviating their uncertainty regarding their medical condition. The research is still ongoing.
Other potential users of the tool consist of people with sleep apnea. The tool is anticipated to go on sale to consumers in six months’ time.